OTC/Supplement Combo Guidance, Sale Urged By Rep. Burton
This article was originally published in The Tan Sheet
Executive Summary
House Government Reform Committee Chair Dan Burton (R-Ind.) is pressing FDA to explain its intentions regarding OTC drug/dietary supplement combination products
You may also be interested in...
OTC/Supplement Co-Packaging Policy In The Works At FDA
Any future FDA guidance or regulation on co-packaging OTCs with dietary supplements would have to reflect the agency's resolution of concerns related to duration of use, dual-labeling and multiple claims for such products
OTC/Supplement Co-Packaging Policy In The Works At FDA
Any future FDA guidance or regulation on co-packaging OTCs with dietary supplements would have to reflect the agency's resolution of concerns related to duration of use, dual-labeling and multiple claims for such products
OTC/Supplement Co-Packaging Policy In The Works At FDA
Any future FDA guidance or regulation on co-packaging OTCs with dietary supplements would have to reflect the agency's resolution of concerns related to duration of use, dual-labeling and multiple claims for such products